Clozapine—balancing the body and the mind

No Thumbnail Available
File version
Author(s)
Siskind, D
Myles, N
Kisely, S
Griffith University Author(s)
Kisely, Steve R.
Primary Supervisor
Other Supervisors
Editor(s)
Date
2022
Size
File type(s)
Location
License
Abstract

In this issue of The Lancet Psychiatry , Jari Tiihonen and colleagues 1 have investigated the slightly increased risk of rare haematological malignancies associated with long-term use of clozapine. This important finding needs to be contextualised to the risks and benefits associated with the use of clozapine for treatment-refractory schizophrenia.

Journal Title

The Lancet Psychiatry

Conference Title
Book Title
Edition
Volume

9

Issue

5

Thesis Type
Degree Program
School
Publisher link
DOI
10.1016/S2215-0366(22)00078-5
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Clinical sciences

Applied and developmental psychology

Clinical and health psychology

Persistent link to this record
http://hdl.handle.net/10072/417294
Citation

Siskind, D; Myles, N; Kisely, S, Clozapine—balancing the body and the mind, The Lancet Psychiatry, 2022, 9 (5), pp. 338-339

Collections
Journal articles